Key facts
- This page summarizes Joseph Walter Vazzano's Form 4 filing for AVENUE THERAPEUTICS, INC. (ATXI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Dec 2021, 16:07.
Joseph Walter Vazzano - 17 Dec 2021 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ATXI
- Reported as of
- 17 Dec 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Dec 2021, 16:07:19 UTC
- Prior SEC filing
- 15 Sep 2021
- Next SEC filing
- 16 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph Vazzano
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Joseph Walter Vazzano filed Form 4 for AVENUE THERAPEUTICS, INC. (ATXI) on 20 Dec 2021.
Change
- Previous filing in this sequence was filed on 15 Sep 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATXI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +100,505
- Change %
- +154%
- Price
- $0.000000
- Shares after
- 165,757
- Date
- 17 Dec 2021
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This restricted stock unit award (RSU) vests on March 15, 2022. Each RSU is equivalent to one share of the Company's common stock.
Footnote F2
Includes 100,505 RSUs.